Exclusive

Publication

Byline

Location

US Patent Issued to Mythic Therapeutics on July 7 for "pH-dependent antigen-binding constructs specific to FOLR 1" (Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,989, issued on July 7, was assigned to Mythic Therapeutics Inc. (Waltham, Mass.). "pH-dependent antigen-binding constructs specific to FOLR ... Read More


US Patent Issued to GlaxoSmithKline Intellectual Property Development on July 7 for "CR2 binding proteins and their use in medical therapy" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,990, issued on July 7, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Great Britain). "CR2 binding proteins and the... Read More


US Patent Issued to MEDICOVESTOR on July 7 for "Methods of crosslinking IgG" (Delaware Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,991, issued on July 7, was assigned to MEDICOVESTOR INC. (Wilmington, Del.). "Methods of crosslinking IgG" was invented by Seah Lim (Wilming... Read More


US Patent Issued to UCB BIOPHARMA on July 7 for "Bispecific antibodies against CD9 and CD7" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,992, issued on July 7, was assigned to UCB BIOPHARMA SRL (Brussels). "Bispecific antibodies against CD9 and CD7" was invented by David Alan ... Read More


US Patent Issued to Revitope on July 7 for "Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells" (Massachusetts Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,993, issued on July 7, was assigned to Revitope Ltd. (Hertfordshire, Great Britain). "Functional antibody fragment complementation for a two... Read More


US Patent Issued to GENMAB on July 7 for "Humanized or chimeric CD3 antibodies" (Dutch Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,994, issued on July 7, was assigned to GENMAB A/S (Valby, Denmark). "Humanized or chimeric CD3 antibodies" was invented by Rik Rademaker (Ut... Read More


US Patent Issued to Janssen Biotech on July 7 for "Materials and methods for modulating T cell mediated immunity" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,995, issued on July 7, was assigned to Janssen Biotech Inc. (Horsham, Pa.). "Materials and methods for modulating T cell mediated immunity" ... Read More


US Patent Issued to INNOVENT BIOLOGICS (SUZHOU) on July 7 for "Protein containing heterodimer antibody Fc, and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,996, issued on July 7, was assigned to INNOVENT BIOLOGICS (SUZHOU) Co. LTD. (Suzhou, China). "Protein containing heterodimer antibody Fc, an... Read More


US Patent Issued to SUMITOMO ELECTRIC INDUSTRIES, SUMITOMO ELECTRIC TOYAMA on July 7 for "Surface-coated metal porous body" (Japanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,240, issued on July 7, was assigned to SUMITOMO ELECTRIC INDUSTRIES LTD. (Osaka, Japan) and SUMITOMO ELECTRIC TOYAMA Co. LTD. (Toyama, Japan)... Read More


US Patent Issued to Beijing University of Technology on July 7 for "Method for in-situ synthesis of tungsten carbide powder" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,241, issued on July 7, was assigned to Beijing University of Technology (Beijing). "Method for in-situ synthesis of tungsten carbide powder"... Read More